MovDisordV3, Ncbi, Merge, bibRecord, 000867

DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.

Identifieur interne : 000867 ( Ncbi/Merge ); précédent : 000866; suivant : 000868

DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.

Auteurs :

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2002.

RBID : pubmed:12211141

English descriptors

KwdEn :
- Benzophenones (pharmacology), Benzophenones (therapeutic use), Bromocriptine (pharmacology), Bromocriptine (therapeutic use), Dopamine Agonists (pharmacology), Dopamine Agonists (therapeutic use), Drug Therapy, Combination, Enzyme Inhibitors (pharmacology), Enzyme Inhibitors (therapeutic use), Ergolines (pharmacology), Ergolines (therapeutic use), Ergot Alkaloids (pharmacology), Ergot Alkaloids (therapeutic use), Humans, Levodopa (therapeutic use), Lisuride (pharmacology), Lisuride (therapeutic use), Nitrophenols, Parkinson Disease (drug therapy), Pergolide (pharmacology), Pergolide (therapeutic use), Randomized Controlled Trials as Topic.
MESH :
- chemical , pharmacology : Benzophenones, Bromocriptine, Dopamine Agonists, Enzyme Inhibitors, Ergolines, Ergot Alkaloids, Lisuride, Pergolide.
- chemical , therapeutic use : Benzophenones, Bromocriptine, Dopamine Agonists, Enzyme Inhibitors, Ergolines, Ergot Alkaloids, Levodopa, Lisuride, Pergolide.
- drug therapy : Parkinson Disease.
- Drug Therapy, Combination, Humans, Nitrophenols, Randomized Controlled Trials as Topic.

DOI: 10.1002/mds.5562
PubMed: 12211141

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 003984
to stream PubMed, to step Curation: 003984
to stream PubMed, to step Checkpoint: 003B48

Links to Exploration step

pubmed:12211141

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12211141</idno>
<idno type="pmid">12211141</idno>
<idno type="doi">10.1002/mds.5562</idno>
<idno type="wicri:Area/PubMed/Corpus">003984</idno>
<idno type="wicri:Area/PubMed/Curation">003984</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003B48</idno>
<idno type="wicri:Area/Ncbi/Merge">000867</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.</title>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Benzophenones (pharmacology)</term>
<term>Benzophenones (therapeutic use)</term>
<term>Bromocriptine (pharmacology)</term>
<term>Bromocriptine (therapeutic use)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Enzyme Inhibitors (therapeutic use)</term>
<term>Ergolines (pharmacology)</term>
<term>Ergolines (therapeutic use)</term>
<term>Ergot Alkaloids (pharmacology)</term>
<term>Ergot Alkaloids (therapeutic use)</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Lisuride (pharmacology)</term>
<term>Lisuride (therapeutic use)</term>
<term>Nitrophenols</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Pergolide (pharmacology)</term>
<term>Pergolide (therapeutic use)</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Benzophenones</term>
<term>Bromocriptine</term>
<term>Dopamine Agonists</term>
<term>Enzyme Inhibitors</term>
<term>Ergolines</term>
<term>Ergot Alkaloids</term>
<term>Lisuride</term>
<term>Pergolide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Benzophenones</term>
<term>Bromocriptine</term>
<term>Dopamine Agonists</term>
<term>Enzyme Inhibitors</term>
<term>Ergolines</term>
<term>Ergot Alkaloids</term>
<term>Levodopa</term>
<term>Lisuride</term>
<term>Pergolide</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Nitrophenols</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">12211141</PMID>
<DateCreated><Year>2002</Year>
<Month>09</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2002</Year>
<Month>11</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>17 Suppl 4</Volume>
<PubDate><Year>2002</Year>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>S53-67</MedlinePgn>
</Pagination>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001577">Benzophenones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004873">Ergolines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004876">Ergot Alkaloids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009596">Nitrophenols</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>24MJ822NZ9</RegistryNumber>
<NameOfSubstance UI="D010479">Pergolide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3A64E3G5ZO</RegistryNumber>
<NameOfSubstance UI="D001971">Bromocriptine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>CIF6334OLY</RegistryNumber>
<NameOfSubstance UI="C066340">tolcapone</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>E0QN3D755O</RegistryNumber>
<NameOfSubstance UI="D008090">Lisuride</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>LL60K9J05T</RegistryNumber>
<NameOfSubstance UI="C047047">cabergoline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001577">Benzophenones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001971">Bromocriptine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018491">Dopamine Agonists</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004791">Enzyme Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004873">Ergolines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004876">Ergot Alkaloids</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008090">Lisuride</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009596">Nitrophenols</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010479">Pergolide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016032">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>48</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2002</Year>
<Month>11</Month>
<Day>26</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2002</Year>
<Month>9</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12211141</ArticleId>
<ArticleId IdType="doi">10.1002/mds.5562</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000867 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000867 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:12211141
   |texte=   DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:12211141" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.

DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki